Human Neutrophil Peptide 1 vs Omiganan — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human Neutrophil Peptide 1 (HNP-1) is the most abundant alpha-defensin in human neutrophil granules, where it constitutes up to 30% of total protein content. Alpha-defensins HNP-1, -2, -3, and -4 are the human versions of the ancestral defensin family....
Calculate Human Neutrophil Peptide 1 dose →Omiganan (CLS001, MBI-226) is a synthetic analog of indolicidin, a bovine neutrophil AMP. It was developed for topical antimicrobial applications including acne vulgaris, catheter-site infection prevention, and rosacea....
Calculate Omiganan dose →| Parameter | Human Neutrophil Peptide 1 | Omiganan |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Completed) |
| Half-Life | Hours (in tissues) | Hours (topical) |
| Typical Dose | N/A | 1-3% gel |
| Frequency | N/A | Twice daily |
| Route | Endogenous (secreted by neutrophils) / Research only | Topical gel/cream |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.